Company: IXHL
Filing Date: 2025-10-27
Form Type: DEF 14A
Source: 0001213900-25-102654
Chunk: 22

Company: Incannex Healthcare Inc.
Filing Date: 2025-10-27
Form: DEF 14A
Chunk 22
---
                  
 October 21, 2024.                                                                                                                          |

Narrative to Summary Compensation Table Annual Base Salary The base salaries of our named executive officers are subject to adjustment and generally determined and approved by the compensation committee of our board of directors or, with respect to our Chief Executive Officer, as recommended by the compensation committee of our board of directors, by our board of directors. The fiscal year ended June 30, 2025 base salaries of each of our named executive officers are described under the subsection titled “ Employment and Service Agreements with our Named Executive Officers” below. Non-Equity Incentive Compensation In addition to base salaries, our named executive officers are eligible to receive annual performance-based cash bonuses, which are designed to provide appropriate incentives to our executives to achieve annual corporate goals and to reward our executives for individual achievement towards these goals. The annual performance-based bonus each named executive officer is eligible to receive is based on the extent to which we achieve the corporate goals that the compensation committee of our board of directors establishes each year and each executive’s individual performance. At the end of the year, the compensation committee of our board of directors reviews our performance against each corporate goal and determines the extent to which we achieved each of our corporate goals and evaluates each individual’s performance. The corporate goals the compensation committee of our board of directors established for the fiscal year ended June 30, 2025 related to regulatory, clinical and development goals, as well as operational and financing objectives. Bonuses are usually determined at the end of the fiscal year and paid in the first quarter of the following fiscal year. 15 Equity Incentive Compensation The 2023 Plan is administered by the Compensation Committee. The Compensation Committee has complete authority to determine which employees, consultants, and/or non-employee directors will be granted Awards under the 2023 Plan. We expect to make certain future awards under the 2023 Plan to our directors and executive officers. An estimate of the amounts of these future equity awards, in the form of restricted stock (the “Expected Awards”), are set forth in the table below.

| Name                     |     | Number of  
 Shares     
 Underlying 
 Expected   
 Awards (#) |            |
| Joel Latham(1)           |     |            | 22,608,692 |
| Joeseph Swan(2)          |     |            |    869,565 |
| Troy Valentine(3)        |     |            | 11,302,608 |
| Peter Widdows(4)         |